期刊名称：EQUINE VETERINARY JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
This unrivalled international scientific journal was first published in 1968 when there were four issues each year. It now appears bi-monthly with 88 pages per issue containing articles with original and potentially important findings. Contributions are received from sources worldwide, including North America, Europe and Australia.
Currently fourth in the scientific citation index, all papers which are published in the journal are subjected to peer review and once articles have been accepted for publication they should appear in the journal within six to twelve months. They present new developments in research being carried out by universities, veterinary schools and institutes devoted to equine and/or comparative physiology, pathology, medicine or surgery and from workers in practice.
The journal strives to publish clinically orientated work and categorises articles into General Articles, Short Communications, Case Reports and Review Articles. General Articles are often accompanied by an Editorial Leader which gives the reader a further insight into a particular topic and provides further reference information.
A combined subscription with Equine Veterinary Education will provide a complete service to the equine veterinarian with access to the latest peer-reviewed original work and information for the clinician assisting with the development of new skills and knowledge and continuing education.
Instructions to Authors
Equine Veterinary Journal (EVJ) publishes original articles and reviews on all aspects of equine veterinary science. Categories include Editorial Leaders, General Articles, Short Communications and Case Reports.
Papers submitted are assessed by at least two referees and, if accepted for publication, the copyright becomes the property of EVJ Ltd. Submitted papers should be accompanied by a signed statement that the paper 1) is original, 2) has not been submitted or published elsewhere and 3) has the approval of all authors. If abstracts only have been published, full papers will be considered but a copy of the abstract should accompany the submitted paper. If reference is made to papers cited as ¡®in press¡¯, 3 copies should be provided. If material is used that has been published elsewhere or is given as a personal communication, it is the author¡¯s responsibility to obtain permission from the publisher and author. The Editor¡¯s decision is final.
Manuscripts and communications on editorial matters should be sent to:
The Editor, Equine Veterinary Journal, 351 Exning Road, Newmarket, Suffolk CB8 0AU, UK.
Tel: +44 (0)1638 666160 • Fax: +44 (0)1638 668665 • Email: viv@evj.co.uk
*Economics of journal production*
From January 1st 2002, the authors of papers submitted to EVJ will be required to pay a fee of £50 towards the cost of the peer review process. This charge is justified to support the considerable costs of the peer review process and it is hoped that it will be acceptable to authors as being modest in the circumstances, since most papers are multi-authored; the kudos of publication in the Journal should also be considered, together with the fact that the assistance given by the peer reviewers is of considerable benefit. AUTHORS ARE REQUESTED TO ENCLOSE PAYMENT WITH THEIR MANUSCRIPTS ON SUBMISSION. (All major credit cards accepted; if you prefer to pay by cheque, these should be in UK pounds sterling, drawn on a UK bank and made payable to EVJ Ltd.)
*NEW - CHANGES IN EVJ INSTRUCTIONS TO AUTHORS*
Effective from 1st June 2003
1) The current heavy submission rate to EVJ has necessitated our making a decision strictly to enforce the current word limit of 4000 words, and 6 pages or less of the Journal, for General Articles. Extra pages on payment of £100 per page will no longer be allowed. The objective is to publish as many papers as possible within as short a period as possible between acceptance and publication.
As a guide, 4000 words, 3 or 4 figures and 2 tables would fit into 6 pages (see article by Holcombe et al. [2001] Equine vet. J. 33, 244-249 in the archive).
2) A new category of articles will be included and welcomed from authors, under the title of Clinical Evidence Articles. The criteria for these are as follows:
• Clinical evidence articles should conform in length to General Articles.
• These articles should describe studies that provide strong clinical evidence.
• The results should demonstrate a significant difference between the outcomes from a study group and a control group.
• A pre-study estimate of the power of the study to resolve a clinically useful difference should be 80% or more.
• The confidence intervals of any results should be provided.
• Articles accepted in this category will be fast-tracked for publication, as are Short Communications, and will be published wherever possible within 3 months of acceptance.
3) Case Reports will be accepted only if they contain no less then 4 cases.
CONTENT
The content of the paper should state clearly the: a) hypothesis being tested, b) objectives, c) study design and d) implications/significance of the study to clinical practice and/or further research.
All papers containing experimental protocols are subjected to ethical review and should contain information regarding ethical standards of the institute of origin.
Reports of clinical trials are welcome but authors are recommended to consult Altman, D.G. (1996) Better reporting of randomised controlled trials: the CONSORT statement. Br. med. J. 313, 570-571.
GENERAL INSTRUCTIONS
Disks
A disk, preferably compatible with Apple Macintosh, Word 5.0/6.0 or QuarkXpress format, is requested on submission of the paper and should be returned with the final revision. If the disk is not compatible, please state the format and word processor used. If a disk is not made available there will be a charge of £70.00 ($110). Please note: on original submission, this disk should contain the manuscript and tables only - figures should be sent as hard copies only, or on a separate disk, at this stage.
Format
All manuscripts, figures and tables should be submitted in triplicate (original and two copies). This includes revised manuscripts. Please save your document in Microsoft Word, formatted for Macintosh. Manuscripts should be typed in double spacing on A4 paper with margins of at least 2 cm and the pages and text lines should be numbered. The first page should include the title, which should accurately describe the subject matter, the name(s) of the author(s), the Institution where the work was done (full postal address/es), any present address(es) and contact details (telephone number, fax number and email address) and about 5 relevant keywords. Authors are also requested to provide a word count. Papers (General Articles) should be no more than 4000 words including references. Division of the paper should be indicated clearly by major headings, subheadings and sub-subheadings.
Doses and measurements should be given in metric (SI) units with /kg bwt added where appropriate. Specialised abbreviations must be explained. Spelling should conform to the Oxford English Dictionary, medical terminology to Dorlands Medical Dictionary and units, symbols and abbrevations should conform to the International System of Units defined by Baron, D.N. (Ed) (1994) Units, Symbols, and Abbrevations: A Guide for Medical and Scientific Editors and Authors, 5th edn. Royal Society of Medicine Press, London. All quantitative results should be analysed by appropriate statistical methods.
Summaries
Summaries (not more than 200 words) are required for General Articles and should contain a statement of the purpose of the work (hypothesis and objectives), methodology employed, conclusions and direct or indirect relevance to clinical practiceand/or research. At the beginning of the Summary, a statement of the hypothesis being tested, the objectives set and an outline of the methods employed, should be inserted. At the end of the Summary, a summary of the results and a conclusion as to the application and clinical understanding of the subject should be made, stating the significance of your study to clinical practice and/or further research.
*New information for 2003: New Summary Format*
From 2003, we are requesting that authors follow the instructions for summaries below and as per the example shown here. The objective is to make the papers contained in the journal more acceptable to clinical readership so as to encourage them to read the paper in full and to understand the reasons why the work was performed; and also to emphasise its potential for clinical relevance and/or the need for further research.
Authors should prepare the Summary carefully and cover the main outcomes of the study under the following headings:
Reasons for performing study: i.e. why the work was undertaken in the first place, the background behind the decision to choose this subject to study.
Hypothesis or Objectives: The statement which is being tested, and is testable by the methods (below); or the original aims of the study, the deliverables.
Methods (of testing hypothesis): Brief description of materials and methods, study design.
Results: Brief highlights of the results obtained.
Conclusions: Conclusions drawn from results.
Potential relevance: The potential relevance/significance of the results to clinical application and/or the need for further research; and/or the need for further work.
In adopting this format, it should be remembered that a Summary is provided to encourage the reader both to think more deeply about the subject involved as well as to read the paper in full. Too much detail can confuse rather than clarify in both aspects of this intention. It is permissible to include data and P value but the work presented should stand upon a full reading of the paper, not on the basis of the Summary itself.
The same applies to conclusions, since it is up to the readers to draw their own conclusions upon the reading of the paper, and care should be taken by the authors not to overstate their conclusions.
Tables
Tables should be referenced in the appropriate place in the text, typed on separate sheets and accompanied by adequate headings and legends. Duplication of data in tables, figures and text should be avoided. Tables should be limited to no more than 3.
Illustrations
Illustrations should be provided when necessary to clarify the text. The legends should be intelligible without reference to the text. Figures should also be referred to in the text. Authors may be charged a fee for publication of more than six illustrations (this includes figures labelled a, b, c etc.). Black-and-white images will be published free of charge (up to this limit), but payment for the production of colour images must be provided at a rate of around £800 per page (every effort will be made to arrange colour figures together, where possible).
Photographs, radiographs and photomicrographs should be presented in triplicate as high quality prints or as originals. The ¡®top¡¯ should be indicated on the reverse side together with the figure number and the author's name. Photomicrographs must state magnification, preferably with a scale bar, and staining technique. Line drawings should be original diagrams on white paper or board. Symbols and lines should be standard and not drawn by hand. Any tables or illustrations which have been published previously should include a suitable acknowledgement to the original source. It is the author¡¯s responsibility to obtain permission for their reproduction.
Illustrations can now be provided digitally on Zip disk or CD-ROM. They must be a MINIMUM resolution of 300 dpi at an image size of 85 mm (width). Illustrations at a resolution of 72 dpi are not acceptable.
Manufacturers¡¯ addresses
The generic name should be given in the text with product name in parentheses, followed by a number indicating a footnote e.g. phenylbutazone (Equipalazone)1. The manufacturer¡¯s details (company name, town/city, state/county and country where manufacturer is based) should then be listed under a heading at the end of the article before the Reference section.
References
References within the text are listed by author(s) and year, i.e. '(Evans 1961; Smith and Jones 1990)' or '¡ reported by Evans (1961)'. Papers with more than 2 authors are cited as et al. i.e Jones et al. (1989). References in the text (within the same parentheses) are listed in chronological order, but the list of references at the end of the article should be alphabetical. References by the same first author and published in the same year should be labelled a, b, c etc within the text (e.g. Smith 1992a) and listed sequentially in the reference list.
The format in the reference list is as follows: author(s) name(s) and initials (with punctuation), year of publication in parentheses, full title of article, journal title as abbreviated in the World List of Scientific Periodicals, volume number and page numbers in full:
e.g. Foster, B.W., Codd, J. and Smith, R. (1992) Effect of stress on ulcers in foals. Equine vet. J. 35, 43-52.
References to book articles should be set out as follows: author(s) name(s) and initials, date of publication in parentheses, title of chapter or article, full title of book, edition/volume if relevant, initials and name(s) of editor(s), publisher, place of publication (town/city) and page numbers in full;
e.g. Robin, C. (1991) Calcium in plants eaten by horses. In: Dietary Calcium, 2nd edn., Ed: J. Chalk, Blackwells Scientific, London. pp 195-201.
Short Communications
These papers will be given priority for publication within the journal. The format for submission described above should be adhered to, but papers submitted as Short Communications should be no more than 2000 words in length including references and should contain no more than 2 figures and 2 tables. A Summary should not be provided for Short Communications.
Proofs
The corresponding author will receive proofs prior to publication. These should be read and returned immediately with corrections and answers to proofreaders' queries. Major alterations will be accepted only at the author¡¯s expense.
Reprints
A reprint order form will accompany the proofs and should be completed and returned with them, whether or not reprints are required. Ordering of reprints after you have returned the proofs will incur considerable expense which would have to be borne by the author(s).
Editorial Board
The Editor, Equine Veterinary Journal, 351 Exning Road, Newmarket, Suffolk CB8 0AU, UK.
Tel: +44 (0)1638 666160 • Fax: +44 (0)1638 668665 • Email: viv@evj.co.uk
|
刊名字顺( Alphabetical List of Journals):
返回页首 